AzTrials
AzTrials

Research institution

Children's Hospital of Philadelphia Clinical Trials

Studies where Children's Hospital of Philadelphia is the lead sponsor: what is enrolling now, by phase, condition and country.

489 registered studies

In numbers

Open to volunteers
88
Active
103
With results posted
147
All registered
489

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 88
  • Survivors of Pediatric Brain Tumors, Pediatric Cancer

    Facial Expression Awareness Training to Understand and Recognize Emotions

    • Recruiting
    • Age: 6 to 13 years
    • Medical device

    The purpose of this research is to find out if a computer-based treatment program, called FaceSay, is a feasible and effective intervention for survivors of pediatric brain tumors (SPBT).

    Trial name
    FEATURE (NCT07923370)
    Testing
    FaceSay, SuccessMaker Reading
    Where
    United States
    Volunteers
    40 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? FEATURE
  • Substance Use Disorders, Parent-Child Relations

    MIO-CPP to Improve the Well-being, Permanency, and Safety Outcomes for Young Children at Risk of or in Out-of-home Placement in Philadelphia and Bucks Counties, and Affected by Maternal Substance Use

    • Enrolling by invitation
    • Age: All ages
    • Lifestyle or therapy programme

    The goal of the project is to improve child well-being, permanency, and safety, and reduce the risk for involvement in the child welfare system for families with children pre-birth to five years who are affected by parental…

    Conditions
    Substance Use Disorders, Parent-Child Relations, Parent Child Abuse
    Trial name
    NCT04294134
    Testing
    MIO-CPP
    Where
    United States
    Volunteers
    320 people
    Sponsor
    Children's Hospital of Philadelphia
  • Hydrocephalus in Infants, Hydrocephalus Acquired

    CEUS Evaluation of Hydrocephalus in Neonates and Infants

    • Recruiting
    • Age: 1 minute to 18 months
    • Phase 2
    • Injection or infusion

    Hydrocephalus affects up to 2 out of every 500 births and results in long-term disability in up to 78% of those affected. The standard treatment of hydrocephalus is cerebrospinal fluid (CSF) diversion via placement of an invasive…

    Trial name
    NCT06693752
    Testing
    Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON]
    Where
    United States
    Volunteers
    20 people
    Sponsor
    Children's Hospital of Philadelphia
  • Rett Syndrome, RTT

    Neurophysiologic Biomarkers in Rett Syndrome

    • Recruiting
    • Age: 1 year to 18 years
    • Observational study

    The goal of this observational study is to identify candidate biomarkers in individuals with Rett Syndrome (RTT). The main questions it aims to answer are: Do these biomarkers change during clinical changes in individuals with…

    Conditions
    Rett Syndrome, RTT, Rett Syndrome, Atypical
    Trial name
    NCT05932589
    Testing
    EEG and Auditory and Visual Evoked Potentials (AEP and VEP), Clinical assessment
    Where
    6 sites in United States
    Volunteers
    222 people, healthy volunteers welcome
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? NCT05932589
  • Cardiac Arrest (CA)

    Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest

    • Recruiting
    • Age: 37 weeks to 18 years
    • Observational study

    This is a prospective, observational, multi-center cohort study of pediatric cardiac arrests. The purpose of this study is to evaluate the physiologic response to epinephrine as an outcome discriminator in pediatric in-hospital…

    Trial name
    PEDICA (NCT07890610)
    Where
    22 sites in United States
    Volunteers
    1,620 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? PEDICA
  • Intubation Complication

    Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

    • Recruiting
    • Age: Up to 19 years

    The purpose of the study is to implement a patient-provider dyad tailored, Electronic Health Record (EHR)-informed, digitized Smart Checklist as a Quality Improvement (QI) intervention to support bedside clinician teams to reduce…

    Trial name
    SMART PICU (NCT06085326)
    Testing
    Smart Checklist
    Where
    6 sites in United States
    Volunteers
    3,000 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? SMART PICU
  • EBV Viremia, CMV Viremia

    25BT056: Basket Study of Viral Cytotoxic T Lymphocytes

    • Not yet recruiting
    • Age: 0 to 29 years
    • Early Phase 1

    This study is evaluating the safety and effectiveness of virus-specific cytotoxic T lymphocytes (vCTLs) for treating difficult-to-control viral infections caused by cytomegalovirus (CMV), adenovirus (ADV), Epstein-Barr virus…

    Conditions
    EBV Viremia, CMV Viremia, BK Viremia, Adenovirus
    Trial name
    NCT07873970
    Testing
    Virus-Specific Cytotoxic T Lymphocytes (vCTLs)
    Volunteers
    35 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? NCT07873970
  • Differentiated Thyroid Cancer, Pediatric Cancer

    Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

    • Recruiting
    • Age: 2 to 99 years
    • Phase 2
    • Surgery or procedure

    Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy.

    Conditions
    Differentiated Thyroid Cancer, Pediatric Cancer, Cancer, Cancer, Thyroid
    Trial name
    NCT05783323
    Testing
    Larotrectinib monotherapy, 131I therapy
    Where
    6 sites in United States
    Volunteers
    13 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? NCT05783323
  • Cardiac Arrest, Cardiopulmonary Arrest

    Quality of Pediatric Resuscitation in a Multicenter Collaborative

    • Recruiting
    • Age: 0 to 18 years
    • Observational study

    This is a prospective, observational, multi-center cohort study of pediatric cardiac arrests. The purpose of the study is to determine the association between chest compression mechanics (rate, depth, flow fraction, compression…

    Trial name
    pediRES-Q (NCT02708134)
    Where
    63 sites in United States, Australia and 13 more
    Volunteers
    7,000 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? pediRES-Q
  • Cardiac Arrest (CA)

    Optimal Ventilation for Cardiac Arrest

    • Recruiting
    • Age: 37 weeks to 18 years

    Pediatric cardiac arrest is a life-threatening problem affecting >15,000 hospitalized children each year. Less than half of these children survive to hospital discharge, and neurologic morbidity is common among survivors.

    Trial name
    OPTI-VENT (NCT07114510)
    Testing
    OPTI-VENT Bundle, Transition, None - control
    Where
    20 sites in United States
    Volunteers
    1,530 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? OPTI-VENT

Completed, with results posted

All 129
  • Adolescent Obesity, Adolescent Overweight

    Helping Educate and Advance Learning Through Healthy Bite-Sized Eating Strategies

    • Completed
    • Age: 14 to 17 years
    • Lifestyle or therapy programme
    • Results posted

    The goal of this clinical trial is to compare the effectiveness of a mobile health intervention in adolescents (14-17 years) with overweight or obesity.

    Conditions
    Adolescent Obesity, Adolescent Overweight, Diet, Healthy
    Trial name
    HEALTHY BITES (NCT06082830)
    Testing
    Intervention
    Where
    United States
    Volunteers
    15 people
    Sponsor
    Children's Hospital of Philadelphia
  • Leukemia, Lymphoma

    Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies

    • Completed
    • Age: Up to 23 years
    • Medical device
    • Results posted

    This is a single-arm study evaluating allogeneic hematopoietic stem cell transplantation (HSCT) using mobilized peripheral blood stem cells from unrelated or partially matched related donors that are ex vivo depleted of α/β T…

    Conditions
    Leukemia, Lymphoma, Myelodysplasia
    Trial name
    AB-CliniMACs (NCT02323867)
    Testing
    CliniMACS α/β T-Cell and CD19+ B-Cell Depleted Peripheral Blood Stem Cell Transplant
    Where
    United States
    Volunteers
    98 people
    Sponsor
    Children's Hospital of Philadelphia
  • Non Malignant Diseases, Immunodeficiencies

    Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders

    • Completed
    • Age: 6 months to 25 years
    • Phase 2
    • Results posted

    This Phase II pilot study evaluates the safety and effectiveness of reduced-intensity conditioning (RIC) regimens prior to allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric and young adult patients with…

    Conditions
    Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies
    Trial name
    RIC (NCT01050855)
    Testing
    Reduced-Intensity Conditioning
    Where
    United States
    Volunteers
    56 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? RIC
  • Genetic Predisposition

    Care Plans for Cancer Predisposition

    • Completed
    • Age: 12 years and older
    • Results posted

    Develop and evaluate acceptability, feasibility, and preliminary efficacy of digital care plan and accompanying text message reminders for children and adolescents with a known Cancer Predisposition Syndromes (CPS).

    Trial name
    NCT05736497
    Testing
    Digital Care Plans
    Where
    United States
    Volunteers
    177 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? NCT05736497
  • Lumbar Puncture

    Ultrasound Assisted Lumbar Puncture in the Neonate

    • Completed
    • Age: Up to 6 months
    • Medical device
    • Results posted

    Clinicians are often unable to successfully do a spinal tap. Ultrasound has been proposed as a method to improve success but it is not known if it helps. This study is designed to see if ultrasound improves the success rate.

    Trial name
    NCT02918149
    Testing
    Palpation Landmark Technique, Ultrasound-Assisted Technique LP
    Where
    United States
    Volunteers
    91 people
    Sponsor
    Children's Hospital of Philadelphia
    Can I take part? NCT02918149

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in